Filing Details

Accession Number:
0001209191-14-043878
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-26 16:54:52
Reporting Period:
2014-06-24
Filing Date:
2014-06-26
Accepted Time:
2014-06-26 16:54:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1432895 Joseph Wayne Riley C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-24 15,000 $33.89 15,200 No 4 M Direct
Common Stock Disposition 2014-06-24 15,000 $98.03 200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-06-24 15,000 $0.00 15,000 $33.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2010-10-09 2020-07-08 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1.
  2. Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 7/9/2010.